Purpose: Women treated for breast cancer often experience cognitive complaints. We studied whether longitudinal changes in resting state functional connectivity from pre-treatment to shortly after chemotherapy could possibly underlie these cognitive complaints. Methods: Fifteen women with early-stage breast cancer scheduled to receive adjuvant chemotherapy underwent resting state fMRI (rs-fMRI) before the start of therapy (t1) and 4 to 6 months after treatment (t2). Fourteen women with early-stage breast cancer who did not receive chemotherapy and 17 matched healthy controls underwent rs-fMRI at matched intervals. Images were preprocessed and warped to MNI space using SPM. Regions within the default mode network (DMN) and frontoparietal net...
Abstract Cognitive complaints after chemotherapy are common in breast cancer patients, but the neura...
Complaints of reduced cognitive abilities are frequent following chemotherapy. Research in the breas...
Abstract Purpose Subsequent to chemotherapy treatment...
PURPOSE:Treatment modalities for breast cancer, the leading cause of cancer-related deaths in women ...
Purpose: A subgroup of patients with breast cancer suffers from mild cognitive impairment after chem...
Several studies in cancer research have suggested that cognitive dysfunction following chemotherapy,...
PURPOSE: Older cancer patients are at increased risk of cancer-related cognitive impairment. The pur...
Chemotherapy may impair cognition and contribute to accelerated aging. The purpose of this study was...
PURPOSE: To examine whether cognitive complaints after treatment for breast cancer are associated wi...
Objective: We aimed to characterize local brain network connectivity in long-term breast cancer surv...
ObjectiveBreast cancer was the most prevalent type of cancer and had the highest incidence rate amon...
Target Audience Researchers and Clinician/Scientists interested in the longitudinal effects of chemo...
ObjectiveBreast cancer was the most prevalent type of cancer and had the highest incidence rate amon...
Comment on Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cog...
Breast cancer (BC) chemotherapy is associated with cognitive changes including persistent deficits i...
Abstract Cognitive complaints after chemotherapy are common in breast cancer patients, but the neura...
Complaints of reduced cognitive abilities are frequent following chemotherapy. Research in the breas...
Abstract Purpose Subsequent to chemotherapy treatment...
PURPOSE:Treatment modalities for breast cancer, the leading cause of cancer-related deaths in women ...
Purpose: A subgroup of patients with breast cancer suffers from mild cognitive impairment after chem...
Several studies in cancer research have suggested that cognitive dysfunction following chemotherapy,...
PURPOSE: Older cancer patients are at increased risk of cancer-related cognitive impairment. The pur...
Chemotherapy may impair cognition and contribute to accelerated aging. The purpose of this study was...
PURPOSE: To examine whether cognitive complaints after treatment for breast cancer are associated wi...
Objective: We aimed to characterize local brain network connectivity in long-term breast cancer surv...
ObjectiveBreast cancer was the most prevalent type of cancer and had the highest incidence rate amon...
Target Audience Researchers and Clinician/Scientists interested in the longitudinal effects of chemo...
ObjectiveBreast cancer was the most prevalent type of cancer and had the highest incidence rate amon...
Comment on Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cog...
Breast cancer (BC) chemotherapy is associated with cognitive changes including persistent deficits i...
Abstract Cognitive complaints after chemotherapy are common in breast cancer patients, but the neura...
Complaints of reduced cognitive abilities are frequent following chemotherapy. Research in the breas...
Abstract Purpose Subsequent to chemotherapy treatment...